Global Longitudinal Strain: Definition, Clinical Context, and Cardiology Overview

Global Longitudinal Strain Introduction (What it is)

Global Longitudinal Strain is a quantitative imaging measurement of how the left ventricle shortens from base to apex during systole.
It is a cardiac imaging metric (a test result), most commonly derived from transthoracic echocardiography using speckle-tracking.
It is often encountered when evaluating heart failure, cardiomyopathies, valvular disease, and treatment-related cardiac dysfunction.
It is used alongside left ventricular ejection fraction to describe systolic function in a more detailed way.

Why Global Longitudinal Strain matters in cardiology (Clinical relevance)

Traditional left ventricular (LV) systolic function is often summarized by left ventricular ejection fraction (LVEF), which estimates the percent of LV blood volume ejected per beat. LVEF is clinically useful, but it can appear “preserved” despite meaningful myocardial dysfunction, especially in early disease or when compensatory mechanisms maintain stroke volume.

Global Longitudinal Strain (often abbreviated GLS after first use) addresses this gap by measuring myocardial deformation (strain), which reflects how myocardial fibers actually contract. In many clinical contexts, a change in GLS can suggest subclinical LV dysfunction before LVEF visibly declines, which may improve diagnostic clarity and earlier recognition of injury patterns. This is particularly relevant in settings such as:

Cardio-oncology, where clinicians monitor for treatment-related myocardial dysfunction.
Heart failure with preserved ejection fraction (HFpEF), where subtle systolic impairment may coexist with preserved LVEF.
Valvular heart disease, where afterload and remodeling can mask dysfunction until later stages.
Cardiomyopathies and infiltrative disease, where GLS patterns can support suspicion of specific etiologies.

GLS can also contribute to risk stratification and longitudinal follow-up, especially when measured consistently over time using similar imaging protocols. How much weight to place on GLS in any one patient varies by clinician and case.

Classification / types / variants

Global Longitudinal Strain is not a disease with stages, but it has practical “variants” based on how it is measured and how results are expressed. The closest relevant categorization includes:

By imaging modality
2D speckle-tracking echocardiography (STE): the most common approach in routine cardiology practice.
3D echocardiography strain: may reduce some geometric assumptions but depends on equipment and image quality.
Cardiac magnetic resonance (CMR) feature tracking: derives strain from cine images; used when CMR is performed for other reasons (e.g., tissue characterization).
By ventricle
Left ventricular GLS: most widely used and best studied.
Right ventricular (RV) longitudinal strain: used in selected scenarios (e.g., pulmonary hypertension, congenital heart disease), but it is a distinct measurement from LV GLS.
By reporting convention
Longitudinal strain during systole is typically reported as a negative value, reflecting myocardial shortening.
In common interpretation frameworks, more negative values generally indicate better longitudinal systolic function, while values that are less negative suggest worse function. Exact “normal” ranges vary by protocol, vendor, and patient factors.
By pattern
Global value: a single summary number across LV segments.
Segmental strain and “bull’s-eye” map: shows regional function and may reveal characteristic patterns (for example, relative apical preservation in some infiltrative cardiomyopathies).

Relevant anatomy & physiology

Understanding GLS starts with LV myocardial fiber architecture and basic cardiac mechanics.

Left ventricle and longitudinal fibers
The LV wall contains layers of myocardial fibers with different orientations.
Subendocardial fibers contribute substantially to longitudinal shortening (base-to-apex motion).
These subendocardial layers are often more vulnerable to ischemia and stress because they experience higher wall tension and may have relatively limited perfusion reserve during increased demand.
Systole and diastole
During systole, the LV contracts and shortens in multiple directions: longitudinal, circumferential, and radial (wall thickening).
GLS focuses on the longitudinal component, which can decline even when overall volume ejection (LVEF) is maintained through other compensations.
Coronary circulation relevance
The left anterior descending artery and other epicardial coronaries supply myocardium, but microvascular function and subendocardial perfusion are also key.
Conditions that reduce coronary flow or increase demand can preferentially affect subendocardial function, potentially changing GLS.
Valves and loading conditions
Aortic stenosis, mitral regurgitation, and hypertension change LV loading conditions (afterload and preload).
Strain measurements, including GLS, can be influenced by these loading conditions, which is important for interpretation.

Pathophysiology or mechanism

GLS is a physiologic measurement of deformation: it quantifies the percentage change in myocardial length along the long axis of the LV during systole.

What “strain” means
Strain is deformation relative to original length.
For longitudinal strain, the LV myocardium shortens in systole, so the strain is typically negative when reported with standard conventions.
The global value is derived by averaging strain across standard LV segments.
How echocardiography derives GLS
In 2D speckle-tracking echocardiography, the software tracks natural acoustic markers (“speckles”) within the myocardium frame-to-frame throughout the cardiac cycle.
By following these speckles, the system estimates motion and deformation, producing segmental and global strain curves.
Accurate tracking depends on image quality, consistent endocardial border definition, and adequate frame rate (specific targets vary by protocol and vendor).
Why GLS can change early
Longitudinal contraction is strongly influenced by the subendocardial myocardial fibers.
Early injury from ischemia, inflammation, toxins, infiltrative processes, or pressure overload can reduce subendocardial function first.
As a result, GLS may worsen before changes in LVEF become obvious, although this is not universal and depends on etiology and patient factors.
Load dependence and physiologic context
GLS is influenced by afterload (arterial pressure/vascular resistance) and preload (ventricular filling).
A change in blood pressure, volume status, or valvular hemodynamics can shift GLS even without a primary change in intrinsic contractility. Interpretation therefore requires clinical context.

Clinical presentation or indications

Global Longitudinal Strain is not a symptom; it is a measurement obtained during cardiac imaging. Common clinical scenarios where GLS is used include:

Heart failure evaluation
Suspected or established heart failure, including HFpEF, when subtle systolic dysfunction is suspected.
Cardio-oncology surveillance
Baseline and follow-up assessments in patients receiving potentially cardiotoxic therapies (use varies by protocol and patient factors).
Valvular heart disease
Aortic stenosis or regurgitant lesions, where strain may reflect myocardial response to chronic loading.
Ischemic heart disease
Assessment of regional dysfunction or recovery patterns in coronary artery disease (often alongside wall motion analysis).
Cardiomyopathies
Dilated cardiomyopathy, hypertrophic cardiomyopathy, and suspected infiltrative disease, where strain patterns can support etiologic thinking.
Myocarditis and systemic illness
Selected cases of inflammatory or systemic disease affecting the myocardium, where conventional metrics may be equivocal.
Monitoring over time
Follow-up of known LV dysfunction to track changes in myocardial performance with therapy or disease progression.

Diagnostic evaluation & interpretation

GLS is interpreted as part of a broader diagnostic picture rather than as a stand-alone diagnosis.

How it is obtained (typical echocardiography workflow)

Performed during transthoracic echocardiography (TTE) using standard apical views (commonly apical four-chamber, two-chamber, and long-axis views).
The sonographer or clinician defines endocardial borders; the software tracks myocardial motion across the cardiac cycle.
The output often includes:
A global value (GLS)
Segmental strain values
A polar “bull’s-eye” plot showing regional distribution

General interpretation patterns (without numeric cutoffs)

More negative GLS generally corresponds to better longitudinal systolic function.
Less negative GLS suggests impaired longitudinal function and may indicate early myocardial dysfunction even when LVEF appears preserved.
Regional reductions can align with coronary territories in ischemic disease, but patterns are not perfectly specific.

Pattern recognition (context-dependent)

Diffuse reduction can be seen in many cardiomyopathies and systemic conditions.
Regional reduction may raise suspicion for ischemia, scar, or localized pathology.
Some infiltrative cardiomyopathies may show recognizable distributions of segmental impairment; however, pattern interpretation varies by clinician and case and should be integrated with other imaging and clinical data.

Key factors clinicians consider when interpreting GLS

Image quality and tracking reliability (poor tracking can mislead).
Rhythm and heart rate (atrial fibrillation and frequent ectopy can reduce reproducibility).
Loading conditions at the time of study (blood pressure, volume status, valvular lesions).
Vendor and software differences, which can produce non-identical values; serial comparisons are most meaningful when done with similar methods.
Comparison with other echocardiographic data, including LVEF, wall motion, LV size, diastolic parameters, right-sided function, and valve findings.

Management overview (General approach)

Because Global Longitudinal Strain is a measurement rather than a therapy, “management” focuses on how GLS informs clinical reasoning and longitudinal care pathways.

Integrating GLS into overall assessment
GLS can complement LVEF when clinicians are determining whether LV systolic function is normal, subtly impaired, or changing over time.
A change in GLS may prompt closer review of possible contributors (ischemia, hypertension, valvular disease, medication exposure, systemic illness), but next steps vary by clinician and case.
Use in monitoring and follow-up
In settings like cardio-oncology or chronic cardiomyopathy, GLS may be used for trend monitoring in conjunction with symptoms, examination, biomarkers (when used), and other imaging.
Serial GLS is most interpretable when acquisition and analysis are consistent.
Relationship to treatment planning
If GLS suggests worsening myocardial function, clinicians may consider whether this aligns with other evidence of cardiac dysfunction and whether additional evaluation is warranted (for example, repeat echocardiography, ischemia evaluation, or CMR in selected cases).
Treatment decisions (medications, device therapy, valve intervention timing) are not based on GLS alone; GLS is one input among many, and practice patterns vary.
Educational value
For trainees, GLS is a practical entry point to understanding myocardial mechanics beyond LVEF, reinforcing concepts of fiber orientation, load dependence, and subclinical dysfunction.

Complications, risks, or limitations

GLS itself does not cause physiologic complications; it is derived from imaging. The relevant considerations are limitations and context-dependent risks tied to the imaging process and interpretation.

Limitations and sources of variability
Image quality dependence: poor acoustic windows (body habitus, lung disease, breast implants, chest wall anatomy) can reduce tracking accuracy.
Arrhythmias: atrial fibrillation, frequent premature beats, or paced rhythms can complicate cycle selection and reproducibility.
Load dependence: changes in blood pressure, volume status, or valvular hemodynamics can alter GLS independent of intrinsic contractility.
Vendor/software differences: different analysis platforms may produce systematically different results; trending is most reliable within the same system and protocol.
Operator and workflow factors: endocardial tracing choices and tracking acceptance can influence results.
Segmental interpretation pitfalls: artifacts, foreshortening of apical views, and suboptimal alignment can create apparent regional abnormalities.
Risks related to the test environment
Standard transthoracic echocardiography is noninvasive and generally considered low risk, but patient comfort, positioning tolerance, and time constraints can affect study quality.
If GLS is obtained via transesophageal echocardiography (less common for GLS) or as part of other procedures, the risk profile depends on that procedure rather than GLS itself.

Prognosis & follow-up considerations

GLS is often used as a prognostic marker in a general sense because it reflects myocardial function, but prognostic meaning depends strongly on the underlying condition, comorbidities, and concurrent findings.

What GLS may contribute
It can support recognition of early LV dysfunction, potentially before overt decline in LVEF in some diseases.
It may help differentiate patients who appear similar by LVEF but differ in myocardial mechanics.
When tracked over time, GLS trends can provide information about trajectory (improving, stable, or worsening function), especially when acquisition is consistent.
What influences outcomes and follow-up
Underlying etiology (ischemic vs non-ischemic cardiomyopathy, inflammatory disease, infiltrative disease, pressure overload).
Severity and chronicity of structural heart disease (LV dilation, hypertrophy, fibrosis when known).
Hemodynamic conditions at the time of measurement (blood pressure, valvular disease severity).
Treatment exposures (for example, cardiotoxic therapies) and whether cardiac function changes over time.
Comorbidities such as chronic kidney disease, diabetes, pulmonary disease, and anemia.

Follow-up intervals and the role of repeat GLS measurement vary by protocol and patient factors. In many practices, repeat imaging is used to answer a specific clinical question (trend monitoring, reassessment after therapy change, or pre-procedure evaluation).

Global Longitudinal Strain Common questions (FAQ)

Q: What does Global Longitudinal Strain measure in plain language?
It measures how much the left ventricle shortens lengthwise during contraction. This reflects the function of myocardial fibers that contribute strongly to longitudinal motion. It is a quantitative way to describe contraction beyond what the eye can see on ultrasound alone.

Q: Is Global Longitudinal Strain the same as ejection fraction?
No. Ejection fraction describes the percentage of blood volume ejected from the ventricle per beat, while GLS describes deformation of the myocardium itself. They often move in the same direction but can diverge, especially in early disease.

Q: Why are GLS values usually negative?
By common convention, longitudinal shortening is represented as a negative strain value because the muscle length decreases during systole. In that convention, more negative generally corresponds to better shortening. Some reports may display absolute values; interpretation depends on reporting style.

Q: If GLS is “abnormal,” does that confirm heart failure?
Not by itself. An abnormal GLS suggests reduced longitudinal myocardial function, but heart failure is a clinical syndrome defined by symptoms, signs, and supportive testing. Clinicians interpret GLS alongside symptoms, examination findings, natriuretic peptides when used, and imaging data like chamber size and diastolic function.

Q: How is Global Longitudinal Strain tested?
Most commonly it is calculated from transthoracic echocardiography using speckle-tracking software applied to standard apical views. It can also be derived from cardiac magnetic resonance feature tracking when CMR is performed. The accuracy depends on image quality and analysis technique.

Q: Can blood pressure or valve disease affect GLS?
Yes. GLS is influenced by loading conditions such as afterload and preload. High afterload (for example, from hypertension or aortic stenosis) can reduce measured strain even when intrinsic contractility is unchanged, so clinicians interpret GLS in hemodynamic context.

Q: Is GLS safe, and does it expose someone to radiation?
When derived from standard transthoracic echocardiography, it is noninvasive and does not use ionizing radiation. The main limitations are technical (image quality and tracking) rather than safety concerns. If measured using other modalities, the safety profile depends on that modality.

Q: What does a change in GLS over time usually mean?
A consistent worsening trend can suggest declining myocardial function, while improvement can be seen with recovery or effective treatment in some conditions. However, apparent changes can also reflect differences in image quality, vendor/software, rhythm, or loading conditions. Serial comparisons are most meaningful when performed using consistent protocols.

Q: Does Global Longitudinal Strain determine whether someone needs a medication or procedure?
GLS can inform clinical decision-making, but it is rarely used as the sole determinant of therapy. Treatment choices generally depend on the full clinical picture, including symptoms, LVEF, structural findings, rhythm, and the suspected cause of dysfunction. How GLS is weighted varies by clinician and case.

Q: If GLS is reduced, can a person still exercise or return to work?
Return to activity depends on the underlying diagnosis, symptom burden, rhythm stability, and overall functional status rather than GLS alone. Clinicians typically integrate imaging findings with exercise tolerance, hemodynamics, and safety considerations. Individual recommendations vary by patient factors and local protocols.

drrehan